The central dogma of DNA enzymology has long held that for two pieces of DNA to be ligated, the respective DNA pieces must bear a hydroxyl on the 3′-end and a phosphate on the 5′-end. All of the other types of DNA ends are considered incorrect or "dirty," as they cannot be joined by classic DNA ligases. However, intrinsic and extrinsic DNA damage often results in broken DNA with dirty ends. Thus, there are a variety of DNA repair enzymes that function to "clean up" or "heal" such dirty ends to promote the restoration of a continuous DNA phosphodiester backbone. Until now, DNA breaks with phosphate at the 3′-end and hydroxyl at the 5′-end also fell into the category of dirty ends. The study in PNAS by Das et al.
The central dogma of DNA enzymology has long held that for two pieces of DNA to be ligated, the respective DNA pieces must bear a hydroxyl on the 3′-end and a phosphate on the 5′-end. All of the other types of DNA ends are considered incorrect or "dirty," as they cannot be joined by classic DNA ligases. However, intrinsic and extrinsic DNA damage often results in broken DNA with dirty ends. Thus, there are a variety of DNA repair enzymes that function to "clean up" or "heal" such dirty ends to promote the restoration of a continuous DNA phosphodiester backbone. Until now, DNA breaks with phosphate at the 3′-end and hydroxyl at the 5′-end also fell into the category of dirty ends. The study in PNAS by Das et al. (1) demonstrates that a recently identified RNAprocessing enzyme, RtcB, can directly ligate a DNA 3′-phosphate end with a DNA 5′-OH end (Fig. 1) .
Conservation of RtcB
RtcB was known to splice tRNA exons with 2′,3′-cyclic-phosphate and 5′-OH ends (2) (3) (4) (5) (6) (7) (8) and possibly plays a role in unconventional splicing of mRNA exons with 2′,3′-cyclicphosphate and 5′-OH ends (4) . Phylogenetic analysis indicates that RtcB enzymes are widely prevalent in bacteria, archaea, and metazoa (2, 4-6), although Escherichia coli RtcB is not expressed under normal conditions (3, 9) . RtcB is absent in fungi and plants, where end-healing enzymes and a classic RNA ligase are used to splice tRNAs (6, 7) . Nevertheless, the high degree of conservation of RtcB in bacteria, archaea, and metazoa, as well as the expression profile of human RtcB (variously named C22orf28, HSPC117, or FAAP), in cancer cell lines (http://discover.nci.nih.gov/cellminer/) are consistent with the enzyme playing an essential role in vertebrate cells. Accordingly, knockdown of RtcB/HSPC117 in cloned mouse embryos leads to placental abnormality, and the mortality rate is 2.5-fold higher than the control group (2). 1A ) and E. coli RtcB (Fig. 1B) . The classic DNA and RNA ligases catalyze a three-step mechanism of adenylate transfer. First, the catalytic lysine residue is charged by adenylylation in an ATP-dependent step. Second, the adenylate is transferred to the 5′-phosphate end of DNA or RNA, generating an activated 5′-end with a pyrophosphate linkage. Third, the 3′-OH carries out an inline attack on the 5′-phosphoanhydride, generating the 3′-5′ phosphodiester bond.
Through a series of elegant biochemical experiments, Shuman and coworkers have elucidated the reaction pathway of RtcB (1, 5, 10, 11). They have now shown RtcB can ligate not only RNA but also DNA ends in a scheme entailing activation of a 3′-phosphate end, the reverse of the strategy used by classic DNA and RNA ligases (cf. Fig. 1 A and B). RtcB carries out the joining of DNA or RNA via a three-or four-step mechanism, depending whether the polynucleotide substrate contains a 3′-phosphate or a ribonucleotide 2′-3′-cyclophosphate end. First, RtcB reacts with GTP and becomes charged by guanylylation at a conserved histidine residue located at the catalytic site, analogous to the classic ligase becoming charged by lysine adenylylation. Second, in the case of a RNA 2′,3′-cyclic-phosphate, RtcB hydrolyzes the cyclic phosphate to a RNA 3′-phosphate end. Next, the guanylate is transferred from the histidine residue to the RNA or DNA 3′-phosphate end, forming an activated polynucleotide-3′pp5′G intermediate, also analogous to the activation of DNA 5′-phosphate ends by the classic ligases. Finally, the RNA or DNA 5′-OH attacks the 3′-phosphorus of RNA/DNA-3′pp5′G to synthesize the phosphodiester bond and release GMP. Each step in the RtcB pathway specifically requires Mn 2+ as the divalent cation cofactor.
Classic RNA and DNA ligases share a core adenylyltransferase domain and an active site composed of conserved amino acid sequence motifs. Classic RNA ligases can be divided into two main classes: the Rnl1 family and the Rnl2 family. Rnl2 ligases, like DNA ligases, prefer to seal 3′-OH/5′-PO 4 nicks in double-stranded substrates. By contrast, Rnl1 ligases prefer to join singlestranded ends, especially within stem-loop structures. The reported substrate preference for RtcB is similar to that of Rnl1. However, the crystal structures of RtcB revealed a novel fold and active site (12) (13) (14) , reflecting the uniqueness of RtcB in terms of its biochemical mechanism.
Potential Functions/Substrates of RtcB
A number of DNA damage or repair processes result in DNA 3′-phosphate ends, including ionizing radiation damage and reactions of many DNA AP-lyases. However, these processes often generate a missing nucleotide at the site of the damage flanked by a 3′-phosphate and a 5′-phosphate, likely requiring more involved DNA repair processes rather than simply ligating across the gap. Chemotherapeutic agents such as bleomycin and neocarzinostatin can also induce DNA damage with 3′-phosphate ends. RtcB offers a novel alternative to repair such lesions.
Class IB DNA topoisomerases (Top1 and Top1mt) transiently form a 3′-DNA-tyrosyl phosphodiester bond during their catalytic mechanism. Trapped Top1 and Top1mt can be removed by tyrosyl-DNA-phosphodiesterase I (Tdp1), leaving a DNA 3′-phosphate end and a 5′-OH end to be ligated. Top1 has also been shown to cleave at single ribonucleotides imbedded in duplex DNA, giving rise to DNA nicks with a 2′-3′-cyclic phosphate end and a 5′-OH end (15, 16) . RtcB is capable of religating such nicks, potentially rerouting them to the normal RNase H2 1) find that E. coli RtcB was unable to seal DNA 3′-PO 4 and 5′-OH ends at a nick in duplex DNA, but it was able to guanylylate the 3′-phosphate end, raising the possibility that the 3′-DNA capping modification could direct or influence further DNA repair/processing steps. They speculate that RtcB-type ligases from other taxa could have different substrate preferences and therefore be adept at repairing duplex nicks with 3′-PO 4 /5-OH termini.
Cellular endonucleases such as DNase II, which is involved in apoptosis, as well as common nucleases including micrococcal nuclease and phosphodiesterase II, generate DNA breaks with 3′-phosphate and 5′-OH. Thus, RtcB potentially can counteract the effects of these nucleases in its ligase capacity or cap 3′ ends for further cellular processing. Finally, RtcB was found to possess high affinity for cruciform DNA (17), a common DNA feature important for regulating biological processes. This intriguing observation may lead to discovery of other important cellular functions of RtcB family of proteins. Now that DNA ligase activity of RtcB has been established, whether this unique biochemical activity plays a role in vivo requires further studies.
As highlighted by Das et al.
(1), it is likely that the unique properties of RtcB will find their use for molecular cloning and genetic engineering studies. Crystal structures of RtcB complexed with DNA substrates (tRNA-like or cruciform DNA) will undoubtedly bring important insights to the functions of this novel family of "reverse ligases." (A) First, the catalytic lysine residues of classic DNA and RNA ligases are charged by adenylylation. Second, the transfer of adenylate to the 5′-phosphate end of DNA or RNA activates the 5′-end with a pyrophosphate linkage. Third, the attack by the 3′-OH on the 5′-phosphoanhydride generates the 3′-5′ phosphodiester bond, releasing AMP. (B) In a GTP-dependent step, RtcB first becomes charged by guanylylation at a conserved histidine residue located at the catalytic site. Next, the transfer of guanylate from the histidine residue to the RNA or DNA 3′-phosphate end generates an activated polynucleotide-3′pp5′G intermediate. Finally, the RNA or DNA 5′-OH carries out a nucleophillic attack on the 3′-phosphorus of RNA/DNA-3′pp5′G and form the phosphodiester bond, releasing GMP.
